| AML | Acute Myelogenous Leukemia Morphologic Classification(FAB분류) &n... |
|---|---|
| CML | Chronic Myelogenous Leukemia * Lymphoid Blastic Crisis(- 1/3)시 치료는 ALL에 준해서 ... |
| AML | acute monocytic leukemia; acute mucosal lesion; acute myeloblastic leukemia; acute myelocytic leukem... |
| CML | carboxymethyl lysine; cell-mediated lymphocytotoxicity; cell-mediated lympholysis; central motor lat... |
| JCML | juvenile chronic myelogenous leukemia |
| AML | Acute Myelogenous Leukaemia |
|---|---|
| CML | Chronic Myelogenous Leukaemia |
| JCML | Juvenile chronic myelogenous leukaemia |
| M2 | myelogenous leukemia |
| myelogenous | Referring to myelocytes, a type of white blood cell. Also called myeloid. (12 Dec 1998) |
|---|
| acute myelogenous leukaemia | <haematology> A rapidly progressing cancer of the blood affecting immature cells of the bone marrow, usually of the white cell population. It is much more common in adults than in children. Symptoms include fatigue, weight loss, fevers, weakness, pallor, bone pains, bleeding gums, nosebleeds, easy bruising, enlarged lymph nodes and joint pains. Treatment includes chemotherapy and/or bone marrow transplant. This leukaemia demonstrates granulocyte differentiation, eosinophilia and Auer rods and is associated with a reciprocal translocation between 8 and 21 (q22;q22), which is the most common translocation in acute myeloid leukaemia and is found more often in younger patients than in older patients. The oncogene involved in this translocation is AML1, which can be detected by Southern blot. Numerical abnormalities, particularly monosomy-7, trisomy-4, trisomy-8, trisomy-21, -Y, monosomy-7 and deletions of the long arms of chromosomes 5 and 7 are quite common in all acute myeloid leukaemia and not restricted to any one FAB classification. Many of these abnormalities are observed at diagnosis and at later stage disease, particularly after chemotherapy. Prognosis is generally more favorable than in FAB-M2 patients showing no translocation, because the latter patients show better remission rates for longer periods of time. Immunophenotyping is useful in diagnosis and expression of one or more of the myeloid antigens CD13, CD14 or CD33 must be detected to make a diagnosis of acute myeloid leukaemia. Acronym: AML Incidence: 2,000 new cases per year in the UK. Origin: Gr. Haima = blood (07 Apr 1998) |
|---|
| myelogenous |
Having to do with, produced by, or resembling the bone marrow. Sometimes used as a synonym for myeloid; for example, acute myeloid leukemia and acute myelogenous leukemia are the same disease.
출처: www.stjude.org/glossary
|
|---|---|
| myelogenous |
The term's literal derivation is "originating from or produced in the marrow". It is applied to leukemias that originate in a marrow stem cell or early marrow progenitor cell, especially acute and chronic myelogenous leukemia. It also distinguishes the myelogenous leukemias, which originate in a cell that is in the blood cell-forming lineages and usually do not affect lymphocytes overtly, from those that originate in a lymphocyte, egacute and chronic lymphocytic leukemia. ...
출처: cll.ucsd.edu/glossarym.htm
|
| myelogenous leukemia |
a type of leukemia in which the cancer develops in the granulocytes or monocytes (myeloid cells).
출처: www.uchicagokidshospital.org/online-library/conten...
|
| myelogenous |
(mye-eh-LAH-jen-us): Referring to myelocytes, a type of white blood cell. Also called myeloid.
출처: www3.mdanderson.org/focus/breast/glossary/DEFS_MP....
|
| myelogenous leukemia |
Leukemia that develops in the myeloid cell lines.
출처: www.leukine.com/patient/290.html
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|